Chevy Chase Trust Holdings, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.

Quarter-by-quarter ownership
Chevy Chase Trust Holdings, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2021$60,000
-16.7%
16,737
-41.2%
0.00%
Q4 2020$72,000
+200.0%
28,473
+469.5%
0.00%
Q4 2019$24,000
-45.5%
5,000
-50.0%
0.00%
Q1 2019$44,000
+131.6%
10,0000.0%0.00%
Q4 2018$19,000
-40.6%
10,0000.0%0.00%
Q3 2018$32,000
-37.3%
10,000
-41.2%
0.00%
Q2 2018$51,000
-23.9%
17,0000.0%0.00%
Q1 2018$67,000
-4.3%
17,0000.0%0.00%
Q4 2017$70,000
-32.7%
17,0000.0%0.00%
Q3 2017$104,000
-18.8%
17,000
+42.9%
0.00%
-100.0%
Q1 2015$128,00011,9000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders